ArticleCancers2022

Multi-Phase, Contrast-Enhanced Computed Tomography-Based Radiomic Prognostic Marker of Non-Metastatic Pancreatic Ductal Adenocarcinoma.

Dong Woo Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.